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1. Introduction 
Modern approaches to science tend to follow divergent paths. On one hand, instruments 
and technologies are developed to capture as much information as possible with the need 
for complex data analysis to identify problematic issues. On the other hand, formulation 
focused, minimalistic approaches that gather only the most pertinent data for specific 
questions also represent a powerful methodology. This chapter will provide many examples 
of the latter by integrating Flow Cytometry (FACS - Fluorescence-Activated Cell Sorting) 
technology with high throughput screening (HTS) of encapsulation systems with extensive 
utility of one-dimensional (1-D) imaging for protein localisation. In this regard, less 
information is acquired from each cell, data files will be more manageable, easier to analyse 
and throughput screening will be significantly enhanced beyond traditional HTS analysis, 
irrespective of the protein concentration present in the background or delivery media. 
1.1 Real-time on-line monitoring of bioprocesses  
The production of heterologous therapeutic proteins is well established in today’s 
biotechnology industry; however their presence during cytometric screening poses complex 
analytical obstacles for food and biotechnologists alike. The Process Analytical Technology 
(PAT) initiative, launched by the Food and Drug Administration (FDA) encourages 
extensive process understanding to achieve the desired quality of pharmaceutical and 
bioactive protein products rather than a ‘quality-by-testing’ approach. Thus, elucidating and 
monitoring variations within protein production, purification and encapsulation systems is 
fundamental for quality control, protein detection and localisation (Glassey et al., 2011). One 
key issue for PAT is the use of on-line process analysers; in this context, ‘on-line’ is used in 
the sense of ‘fully automatic’ or ‘without any manual interaction’. 
The foundation of early microscopy and its transition to the modern FACS nowadays, 
proved that cell growth within a population differs significantly from one cell to another. 
These heterogeneities are caused by either fluctuations in the micro-environment of 
individual cells (Dunlop and Ye, 1990); phenotypic changes during the cell cycle (Münch et 
al., 1992); or by mutations resulting in genotypic variations in the population (Hall, 1995) 
leading to different protein expression levels. Thus, the most important variable in a 
bioprocess - cell productivity of a heterologous protein product - is distributed over a wide 
range within the cell population. Protein analytical methods (i.e. SDS-PAGE, Western blot,  
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MALD-TOF-MS) are off-line, time and cost intensive, require human interaction and are not 
capable of exhibiting protein expression levels in single cell level. Earlier studies 
demonstrated that tagging the target protein with a fluorescent reporter molecule (green 
fluorescent protein GFP) permits detection of low protein concentrations by measuring the 
reporter molecule’s specific fluorescence (Broger et al., 2011). Specific protein fluorescence 
signals can be measured through on-line, in situ fluorescence sensors (Jones et al., 2004, 
Reischer et al., 2004); but the main drawback of these measuring techniques is that they all 
result in population averaged data; hence analysis of single cell productivity was not 
possible. As mentioned FACS is one of the available methods for measurement of 
population distribution and has been exploited in biotechnology (Rieseberg et al., 2001). To 
overcome this disadvantage of FACS as an off-line analyser, a number of flow injection (FI) 
flow cytometer systems have been designed for the determination of proteins (Kelley, 1989). 
Ruzicka and Lindberg (1992) were the first to utilise FI as an interface between a bioreactor 
and FACS. Further progress in FI-FACS has been made by Srienc and co-workers (Zhao et 
al., 1999), examining population dynamics of Saccharomyces cerevisiae (Kacmar and Srienc, 
2005) and growth dynamics of Chinese Hamster Ovary (CHO) cells and their associated 
proteins (Sitton and Srienc, 2008a, b). None of them, however, measure single-cell productivity 
using fluorescent reporter tag co-expressed with target protein, which restricts the 
purification of secreted protein products. 
1.2 Efficacious phenotypic analyses of cell encapsulation systems 
Cellular detection and characterization usually involves cell harvesting for more than 20 
generations in order to achieve the formation of macro-colonies on solid media. What is 
more, encapsulation provides an innovative solution for the handling and use of live cells 
through the use of three-dimensional scaffolds. These scaffolds - commonly known as beads 
or capsules - can be used in a number of ways, such as for the isolation of individual cells to 
form clonal populations, for establishing partial barrier for cells from their environment, and 
for creating a matrix allowing the formation of 3D-cell cultures or clusters. These methods 
have important implications for the biomedical engineering field and the areas of 
biomanufacturing and bioprocessing. Nonetheless, a myriad of information remains to be 
discovered. For example, the chemical composition and engineered functionalities of these 
scaffolds affect the biology of the encapsulated cells. One particular system that has recently 
achieved significant recognition are the dairy proteins. A variety of cell types can be 
enclosed in casein or whey beads scaffolds in a range of sizes. While maintaining their 
morphology and function, these encapsulated cells can proliferate, form cell clusters, and 
even lay down extracellular matrix components. Furthermore, cells can be encapsulated in 
small particles that can then be handled, characterized and analysed with ease. These 
features make milk proteins an attractive encapsulation material for three dimensional 
scaffolds of live cells. Meanwhile, HTS of these encapsulated cells is restricted by several 
practical aspects including low sample throughput, protein matrix limitations and the 
absence of sorting capability for mixed cell cultures. Hence, a unique reconsideration of 
conventional cytometric approaches for accelerated food and/ or bioprocess intensification 
represents a timely research strategy for encapsulation technologists and cytometrists alike. 
It was recently discovered (Delgado et al., 2010) that microbial growth can be monitored in 
encapsulated cell systems by following the development of micro-colonies. Therefore, 
development and dissemination of a FACS technology capable of analysing encapsulated 
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cells within intact micro-capsules encapsulation systems would represent a novel cytometric 
strategy for academic and industrial applications. This approach would require knowledge 
management of cytometric control parameters, which would generate reduced capital cost, 
human error and environmental deterrents associated with conventionally high-throughput 
screening strategies. However, there is a need for addressing physico-chemical properties of 
micro-capsules for efficient cytometric screening without i) occlusion of capsular flow in the 
fluidics system during hydrodynamic focusing or ii) adverse interactions between protein 
(originating from the micro-capsule or cell metabolic activity) and cytometric buffer media 
during the screening process.  
Delgado et al., (2010) demonstrated that cell proliferation within encapsulation systems can 
be detected via FACS, provided that the population of capsules exhibit appropriate optical 
and mechanical properties and are mono-dispersed in size and shape. Encapsulated cells 
can be further utilized for a variety of applications: from characterizing secreted enzymes to 
detection of thermo-sensitive mutants. Delgado et al., (2010) successfully revealed the 
application of Flow Focusing® technology for microencapsulated cells of different types in 
mono-disperse hydrogel microspheres. Using a CellENA® Flow Focusing® microencapsulator, 
monodisperse capsules were fabricated containing one single cell with sizes ranging from  
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Source: (Delgado et al., 2011). http://www.cellena.net/en/documents/CellenaPoster.pdf 
Fig. 1. Data detecting glutenases in micro-encapsulated bacteria. Colonies of bacteria were 
grown in gliadin-containing capsules. Images on the right illustrate the change in fluorescent 
intensity as a function of incubation time in culture media after micro-encapsulation. Gliadin 
content was detected by incubating the particles with the monoclonal antibody G12, 
conjugated to FITC. The micrograph on the left illustrated colonies of bacteria growing 
gliadin-containing micorparticles (Delgado et al., 2011) 
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100 μm to over 600 μm diameter. This offers a plethora of applications including the 
characterization of secreted therapeutic proteins to detect encapsulated cells or thermo-
sensitive mutants. More importantly, cell proliferation inside the micro-capsules was 
detected by FACS without the need for fluorescent labelling, which represents a significant 
development (Delgado et al., 2011). Furthermore, bacteria expressing glutenase activity, 
isolated from agrochemical samples were detected by their ability to degrade gliadin when 
growing inside capsules as shown in Figure 1. Gliadin content was detected by incubating 
the particles with the monoclonal antibody G12, conjugated to FITC (Delgado et al., 2010). 
Further information relating to COPAS analysis can be obtained from Union Biometrica 
(http://www.unionbio.com/). 
Figure 2 illustrates capsules containing yeast colonies incubated for different times. Data 
revealed that capsules had a similar size (Time of Flight; TOF) but differed in optical 
complexity (Extinction; EXT). Hence, different yeast concentrations were predicted as a 
function of time. This Flow Focusing® Technology from Union Biometrica, Belgium, will 
inevitably bring additional utility and commercial recognition to FACS as an economically 
viable biochemical application for improved analytical monitoring of downstream 
processing during fermentation and drug/ protein generation. Figure 3 illustrates the 
successful analysis of protein capsules based on size (TOF) and extinction (EXT). The best 
resolution was obtained with the 561nm solid state laser due to higher penetration into the 
protein capsule, which will depend upon membrane thickness, coating or presence of a  
 
Source: (Delgado et al., 2011). http://www.cellena.net/en/documents/CellenaPoster.pdf 
 
Fig. 2. Optical density (Extinction; EXT; x-axis) measurements of encapsulated yeast 
following the time points indicated (above, the images of the encapsulated yeast) 
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surface cross-linker. It was also demonstrated that maximum peak height can be used as a 
sorting parameter for cytometric sorting of encapsulated cells in protein capsules. Further 
research is currently being conducted in this promising area of cytometric analysis. 
 
Fig. 3. Displays the dot plots TOF vs. EXT for empty protein capsules. TOF is an indicator of 
size, while EXT represents the density of the detected object 
These developments may aid bioprocessing technology, improve process development and 
analytical control by sorting cells based on i) micro-capsule size; ii) cell type; iii) cell density; 
iv) monoclonality and v) protein expression. In this way, fluorescent tagging is not an 
essential requirement for the characterisation of encapsulated cell cultures and their 
respective recombinant proteins, which demonstrates a significant development for cost- 
and time-efficient cytometric screening. Moreover, encapsulation evaluation using Flow 
Focusing® Technology, can be used for phenotypic analysis of encapsulated cells, such as 
the expression of specific characteristics of microbial colonies (glutenase expression by 
bacteria) or growth-related phenotypes (antibiotic resistance and proliferation in thermo-
sensitive yeast). Mammalian cells are delicate, difficult to handle and manipulate 
individually. However, these cells can be encapsulated within a polymer material such as 
protein or alginate, and these encapsulated scaffolds remain intact throughout all steps of 
cytometric analysis and dispensing. Furthermore, fragile cells like adipocyte stem cells 
remain viable for extended periods of time (2 weeks) (Delgado et al., 2010) and can be 
released and recovered to permit further analysis and use, which endorses an exclusive 
cytometric development. 
1.3 High throughput processing of encapsulated bacterial libraries 
Industrial interest in encapsulation has grown exponentially in the fields of bioprocessing, 
fermentation and elucidation of bacterial libraries, especially in high-throughput 
environments exceeding 106 samples per day. Fundamental pre-requisites reveal the 
necessity for a one-to-one relationship between individual cells and analytical algorithms. 
Essentially, each micro-carrier (i.e. capsule) would therefore contain exactly one cell or 
colony. However, synthesis of larger numbers of capsules containing exactly one cell is not 
feasible as cells are randomly distributed during capsule production. The problem is clear - 
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high dilution conditions will yield an adequate degree of monoclonality; however, this will 
be coupled with the generation of a significant fraction of empty micro-capsules. 
Conversely, distribution under low dilution conditions will generate unacceptable numbers 
of polyclonal capsules for whose removal no satisfactory technologies exists to date. Recent 
finding demonstrated (Walser et al., 2008, 2009) that hydrogel micro-carriers can be applied 
as growth milieu for individual cell colonies. Escherichia coli cells expressing green 
fluorescent protein (GFP) were encapsulated at low dilution thereby intentionally producing 
a considerable amount of polyclonal micro-carriers. Empty and polyclonal micro-carriers 
were then removed from the desired monoclonal fraction using a particle analyzer. Data 
was compared to model predictions in order to investigate possible limitations in the 
analysis and sorting of monoclonal micro-carriers. Fluorescent E. coli cells (GFP) were 
randomly distributed throughout the micro-carrier population and cells successfully 
propagated to colonies in the micro-carrier with enrichment to 95% monoclonality. 
Interestingly, colony diameter represents a limiting factor for enrichment-efficiency in 
encapsulation systems. With increasing colony size, two antagonistic effects are associated 
with the cytometric approach: First, improved sorting efficiency due to increased 
fluorescence intensity and thus higher detection efficiency, and second, deterioration of 
sorting efficiency due to occlusion occurring in polyclonal micro-capsules. Hence, 
encapsulation under low dilution conditions with high-throughput sorting via FACS 
represents a practical economically viable initiative for isolating large quantities of 
monoclonal micro-capsules from bacterial libraries and at the same time, keeping the 
amounts of empty micro-capsules at a moderate level. 
1.4 Utilization of micro-capsules for next generation cytometric assays 
It is evident that cytometric screening is a pragmatic approach for integration of cell 
encapsulation within continuous bioprocesses. Subsequent segregation and sorting of 
microcapsules containing high cell densities of animal cells and associated proteins has 
recently catalysed interest in cytometric screening. Research performed by Union Biometrica 
Inc. (www.unionbiometrica.com) applied this technology and found COPAS™ (Complex 
Object Parametric Analyzer and Sorter) suitable for automated analysis, sorting, and 
dispensing of ‘large’ objects such as capsules. The COPAS™ PLUS is capable of analysing 
particles with diameters of 30 - 800 μm in a continuously flowing stream at a rate of 25-50 
objects/second. Physical properties such as size, optical density and intensity of fluorescent 
markers are taken into consideration. To avoid damaging or changing the fragile biological 
samples, a gentle pneumatic device located after the flow cell is used for sorting 
encapsulated cells and therefore makes the instrument suitable for handling live biological 
materials or sensitive proteins (Figure 4). It is interesting to note that the fluid pressures of 
the instrument are also significantly lower than those of traditional flow cytometers. The 
COPAS™ XL instrument has a 2,000 μm flow cell, which allows the analysis of larger beads 
(30-1,500 μm) compared to the COPAS™ PLUS. If an encapsulated sample contains certain 
fluorophores that can be excited by light of 488 nm, the emission levels can be detected for 
each of the objects in the encapsulated system.  
Figure 4 details the analysis of intact encapsulation capsules inside the flow cells. Objects are 
carried through the flow cell by a liquid stream while their physical properties are being 
measured. Convergence of the sheath and sample fluid allows “hydrodynamic focusing” of 
the micro-capsules, forcing them to go through the centre of the flow cell along their  
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(a) 
 
(b) 
Fig. 4. Schematic of Flow Focus Technology™ shown in (a). Figure (b) illustrates a schematic 
(left) and an image (right) of the spectral detection leg constructed on the open face of the 
COPAS™ flow cell (Watson et al., 2009). DM: dichroic mirror; L1: 80 mm spherical lens;  
L2: 6 mm cylindrical lens; FC: flow cell; L3, L4: 21 mm aspherical lenses; OF: optical fiber; 
ND: 0.8 OD neutral density filter 
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longitudinal axes. Inside the flow cell objects are illuminated by two low energy lasers that 
measure the microcapsule optical properties inclusive of size, optical density and 
fluorescence. Micro-capsules that meet the sort criteria are permitted to drop into sort 
collection, while those that do not are diverted to waste recovery using a pneumatic sorting 
device. Cells may be classified according to their fluorescent intensity or optical density, 
which will accommodate a greater efficiency for detection of recombinant proteins during 
encapsulation procedures. Preliminary studies performed using COPAS™ instrumentation 
has demonstrated the discrimination of hydrogel microcapsules containing mixed cell 
cultures. During initial sampling, micro-capsules were selected based on their size (TOF), 
monoclonality and optical density (EXT). Preparation of a standard curve using micro-
capsules of known size and TOF measurements provided a practical correlation between 
TOF measurements generated by the flow cytometer and the actual size. Hence, it is 
plausible to select micro-capsules that meet specific size and optical density criteria. 
Furthermore, encapsulated cells can also be chosen to meet criteria of size, optical density 
and levels of green and red fluorescence. Hence, it is also possible to sort micro-capsules 
with various magnitudes of cell growth, cell density and recombinant protein content.  
Watson et al., (2009) successfully adapted Union Biometrica COPAS™ Plus instrument to 
allow red excitation and optical fiber-based light collection and spectral analysis using a 
spectrograph and CCD array detector (Figure 4B). These modifications did not compromise 
the ability of the instrument to resolve different sized capsules based on their extinction 
(EXT) and time of flight (TOF) signals. The modified instrument has the sensitivity and 
spectral resolution to measure the fluorescence and Raman signals from individual particles 
with signal integration times of 10 usecond. The high speed spectral analysis of individual 
particles in flow will enable new applications in biological encapsulation systems 
2. High content screening – getting more for less 
High content screening (HCS) can identify proteins via automated image analysis and, in 
general, is designed to capture image information regarding cells and associated protein 
products. The availability of commercial imaging systems has made HCS increasingly 
practical for protein determination and has placed HCS into a standard tool for protein and 
drug discovery (Zanella et al., 2010). The value of this protein determination approach is 
apparent since a vast number of cellular characteristics can be captured in large data files. 
Over the past decade advances in information technology and biological probes have led to 
practically automated image analysis with throughput far above that possible by manual 
cell analysis in protein-rich environments. Several commercial instruments are now 
available for HCS of proteins, for example the BD Pathway (BD Biosciences), In cell Analyzer 
(GE healthcare), ImageXpress Ultra (Molecular Devices) and Scan^R (Olympus), to name a 
few. The Imagestream (Amnis) is a relatively new instrument that combines aspects of FACS 
with image analysis, resulting in a device capable of imaging cells at multiple fluorescent 
wavelengths with a throughput of hundreds of cells per second (Reardon et al., 2009). In 
HCS devices, the presence of environmental protein presents trade-offs between the 
quantity (and quality) of data acquired and throughput. Hence, environmental protein is a 
hindrance to the efficacy of cytometric screening. The Imagestream, for example, trades 
ultrahigh image resolution for speed, and many cellular images are captured in one data 
file, the size of which can easily exceed 3 gigabytes.  
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3. Cytometric limitations associated with environmental protein 
Contemporary approaches to food fermentations and drug discoveries frequently use HTS 
to measure the fluorescence of cellular features tagged with fluorochrome-conjugated 
antibodies or other fluorescent labels in a very rapid manner. This is quite often performed 
by FACS, a technique well-suited to this purpose. However, tagged cells are often entrapped 
within a dense protein matrix or lattice, which represents an obstacle against true microbial 
counts. Hence, applications can be significantly hindered by the presence of proteins since 
environmental protein particles, matching the size range of cells, are often recognised as 
cellular bodies during hydrodynamic focusing. An appropriate methodology is therefore 
required to eliminate interfering environmental protein - non-cellular in origin - from 
cytometric analysis for successful application of cytometric screening. Traditional FACS can 
easily capture emissions from ten or more different fluorochromes on a cell at rates 
exceeding 25,000 cells per second. Although this is appropriate for many assays, FACS 
cannot provide accurate details on cell morphology or subcellular localisation of 
fluorescence in the presence of obtrusive environment protein. In the interim, manual 
microscope examination of fluorescent staining can provide information for these 
characteristics. However, this approach can be too subjective and lowers throughput 
substantially. Hence, environmental protein originating from e.g. encapsulation matrices or 
carrier media may exhibit adverse effects for accurate cytometric analysis. 
4. Flow Cytometry for cell viability assessment in complex protein matrices  
Proof of principle that product quality can be assessed within complex systems using FACS 
may raise awareness and further develop cytometric technologies within the industrial 
domains of quality management and product /process optimization. Rapid and efficient 
viability assessment is essential for regulation and legislation on therapeutic bioactives or 
drug product quality. Hence, there is a clear need for real-time cell enumeration techniques. 
Data procurement in minutes rather than days may identify a problem faster than usual. 
Within the food industry, FACS represents a major development for high throughput 
screening (HTS) of high cell density cultures in addition to providing real-time quality 
control. Numerous technologies, inclusive of FACS have been developed to accelerate data 
acquisition compared to traditional culture methods. In the food industry, techniques 
utilizing antibodies for cell labelling prior to FACS analysis have been developed for 
Salmonella enterica serovar Typhimurium and Listeria monocytogenes in milk and other dairy 
products (Patchett et al., 1991). Moreover, Doherty et al., (2010) demonstrated that FACS, 
coupled with fluorescent techniques, can be successfully applied for the assessment of cell 
viability in seven different protein matrices ranging in structural complexity. Food 
containing complex protein matrices can frequently generate unpredictable results 
regarding cell viability. Cell entrapment within protein networks can severely affect 
accurate cell enumeration, an issue which requires special attention as it has an impact on 
both quality and safety of the product. Cell viability can be accurately determined by FACS, 
specialised for cell encapsulation and protein systems. The distinctive features of this 
strategy can be summarised as follows: while Delgado et al., (2010) performed cytometric 
screening on encapsulated cells within intact micro-carriers, Doherty et al., (2010) 
enumerated cell viability following complete protein matrix digestion. Cell extraction and 
digestive pre-treatments were designed to liberate cells from the scaffold in order to minimise  
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the protein background, the predominant compositional obstacles for efficient FACS 
analysis. It is interesting to compare the success of these reverse strategies for use in 
encapsulation systems. Cell extraction by Doherty et al., (2010) required 40-minute sample 
preparation and distinct functional cell populations were discriminated based on 
fluorescent labelling by of Thiazole Orange (TO) and Propidium Iodide (PI). This assay 
yielded 45–50 samples/hour, a detection range of 102–1010 cfu mL-1 of homogenate and 
generated correlation coefficients (r) of 0.95, 0.92 and 0.93 in relation to standard plate 
counts during heat, acid and storage trials, respectively. This cytometric approach could 
also alleviate problems relating to environmental compatibility during the production of 
nutraceutical products; a formulation problem generating a strong current of industrial 
activity. However, uptake of this technology is dependent on cost-efficiency and the scope 
for extension of product applications. Both of these pre-requisites are satisfactory for food 
and pharmaceutical manufacture environments due to the i) multi-disciplinary function of 
the assay for cell viability assessment; ii) minimal personnel training required for 
instrument commission and iii) rapid, reproducible cytometric signature responses in a 
variety of encapsulation matrices in the presence of protein. The timely availability of 
cytometric results also provides manufacturers with the necessary skills to promote 
problem-solving investigations in bioactive and/ drug development for enhanced 
performance of therapeutic cultures with subsequent detection and utilisation of 
recombinant proteins. 
4.1 Significance of a protein clearing procedure  
Flow Cytometry is commonly associated with inaccuracies due to its basic operating 
principle involving ‘hydrodynamic focusing’ whereby each particle, either cell aggregate or 
single bacterium, is counted as one cell (Maukonen et al., 2006). Hence, fluorescent 
techniques like FACS are not universal and successful application necessitates detailed 
tailoring of pre-treatments and buffer compositions for cell lines and product types. 
Previous research (Bunthof and Abee, 2002, Gunasekera et al., 2000) failed to generate a 
procedure capable of consistent cellular discrimination within a diverse range of protein 
environments inclusive of dairy scaffolds, clinical protein supplements and encapsulation 
polymers. This challenge is associated with the fluctuating proteolysis response of various 
protein environments due to differing structural orientation and protein complexity. 
Doherty et al., (2010) optimised sample pre-treatments (Figure 5) buffer composition and 
probe concentrations in order accurately detect live, injured and dead cells within 
encapsulation systems. Moreover, this strategy liberated cells from encapsulation and 
protein networks without any adverse cellular injury as visualised in Figure 6.  
The assay advocates rapid, reproducible cell liberation compared to lengthy extraction 
procedures previously reported for immobilized systems (Sun and Griffiths, 2000). Since 
cells are in the micron range, the signal-to-noise ratio in FACS analysis is of paramount 
importance especially in clinical protein supplements, which are normally viscous in nature. 
More importantly, encapsulation polymers and protein matrices will inevitably generate 
increased particle scatter due to high concentrations of colloidal particles in the cell size 
range. It is evident that protein clearing strategy is fundamental for the achievement of 
reproducible reliable cytometric viability screening in dense environmental milieu 
commonly encountered in drug and cell delivery models. 
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        (e) 
Fig. 5. Flow cytometric dot plots illustrating probiotic bacteria Lb. rhamnosus GG 
encapsulated in protein gel matrix and pre-sample extraction (a), post-homogenization  
(b) and after proteolysis digestion of the protein capsule (c). Results also demonstrated the 
clear distinction between live (c), injured (d) and dead probiotic cells (e) 
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200 μm
 
Fig. 6. Confocal image visualising the release of live probiotic bacteria from intact 
encapsulation scaffolds (left) and their progressive digestion during the protein clearing 
procedure (left- right) 
4.2 Cell release mechanism for enhanced cytometric screening 
Current research illustrates a poor correlation between standard plate counts and cytometric 
screening due to non-specific binding of fluorescent dyes to protein particles (Gunasekera et 
al., 2000), which failed to be adequately removed by enzymatic treatments or commercial 
protein-clearing agents (McClelland and Pinder, 1994a, b). Meanwhile, Doherty et al., (2010) 
further resolved the negative effect of environmental proteins by introducing a mild 
homogenisation step in order to break-down cellular chains for the provision of true 
cytometric cell counts. Essentially, this two-stage pre-treatment substantially reduced 
particle counts or cytometric ‘events’ that were similar in size to, or larger than typical 
cellular dimensions i.e. 1 to 5 µm (Figure 7). Interestingly, further physico-chemical analysis 
e.g. zeta potential and hydrophobicity, provided details of charge interactions within 
protein-cell systems. This procedure allows to release of clean cell populations from 
complex or encapsulated protein matrices (Doherty et al., 2010).  
4.3 Optimum compensation and fluorescent staining  
Spectral overlap of the different fluorochromes used during FACS, if uncorrected, will lead 
to misinterpretation of data from false positives or artifactual populations. Compensation 
values in excess of 90% have been reported (Gunasekera et al., 2000, Gunasekera et al., 2003), 
which can be substantially reduced by pre-treatment to values as low as 28%, which may 
alleviate distortion of true viable counts. Pre-treatment of the preparations can influence 
fluorescence compensation values via optimization of instrument settings and equilibration 
of overlapping spectral channels. Despite dense protein environments in some products, the 
regression between FACS and plate counts can closely match the guidelines of Feldsine et al., 
(2002) for validation of qualitative and quantitative microbiological methods. Since all 
matrix material in the size range of cells can be adequately digested, cell overestimation as a 
result of matrix staining during FACS analysis was reduced. However, these findings may 
be interpreted as evidence of a dormant or an active but non-culturable cell condition, since 
Lahtinen et al., (2005) discovered a subpopulation of non-culturable cells with a functional 
cell membrane typical of viable cells. Interestingly, non-viable probiotic cells can also 
illustrate adherence to intestinal mucus for subsequent conveyance of immunomodulatory 
effects (Ouwehand et al., 2000, Vinderola et al., 2005). Therefore, the detection of compromised  
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(a)  
 
(b) 
Fig. 7. Fluorescent Confocal Scanning Laser Microscope (CSLM) images showing the 
incomplete protein digestion (a) generated after single protein digestion and the 
homogenous cell suspension generated (b) for FACS analysis following cell extraction and 
double proteolysis 
cells or possibly dead cells may be screened by FACS for the provision of therapeutic cell 
cultures. Furthermore, Maukonen et al., (2006) highlighted the choice of fluorescent stain, 
sample pre-treatment and product matrix as additional cytometric factors influencing cell 
stainability, contrary to general credence based solely on strain characteristics. Retention of 
fluorescent dyes is synonymous with hydrophilic cell surface properties, both of which were 
illustrated for probiotic bacteria Lactobacillus rhamnosus GG by Doherty et al., (2010). 
Interestingly, surfaces of lactic acid bacteria studied in literature are also hydrophilic 
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(Boonaert and Rouxhet, 2000, Pelletier et al., 1997). This acquired knowledge relating to 
cytometric screening of protein-cell systems will diversify the choice of cell lines and the 
product range applicable for efficacious cell delivery via encapsulation. 
4.4 Next generation flow cytometry for encapsulation applications 
As conventional flow cytometers with advanced capabilities mature as large powerful 
laboratory systems for obtaining highly complex information, a new generation of ‘personal 
flow cytometers’ have evolved. These bench-top user-friendly cytometers focus on specific 
functions (Vignali, 2000) and include less flexible laser selection systems (Shapiro, 1995), less 
sensitive detectors (www.accuricytometers.com) and/or elimination of sheath fluid 
(www.millipore.com). These smaller systems can accomplish most customary tasks, 
including cell counting, measurement of cell viability, antibody quantification and detection 
of cell death. The Luminex® family of cytometers, in particular, have advanced the use of 
micro-particle-based assays to provide multiplexed analytical capability while keeping the 
optics relatively simple. With recent developments in micro-fabrication and microfluidics, 
such as small, optimised chip design, developers are miniaturising current cytometers even 
further to create systems for point-of-use applications and some of these systems will 
continue to employ particle-based assays (Kim et al., 2010).  
Micro-particle assays often rely on antibodies as capture molecules on the surface of the 
capsule. Although, other types of capture molecules can be used, the high specificity and 
affinity of antibodies in the presence of complex sample matrices has made them a reagent 
of choice. In 1977, Horan and Wheeless published a manuscript in Science detailing the first 
microsphere-based immunoassay (Horan and Wheeless, 1977). Since then, others have 
followed with technology of increasing sophistication (Vignali, 2000). Capture antibodies are 
generally immobilized onto the micro particles using available reactive groups, for example 
amines, hydroxyls or thiols but carboxyls are the most frequently used. Functionalisation of 
carboxyl is followed by exposure to ethydimethylaminopropylcarbodiimide and N- 
hydroxysuc-cinimide, which provides a mild procedure for antibody attachment to the 
surface of micro-particles. The attached antibody can captures antigen from a sample on to 
the surface for the microsphere. The signal can then be generated as an aggregation event 
measured using light scattering or electrical or magnetic properties. More frequently, a 
fluorescent tracer is included in the particle-capture antibody-antigen complex, and 
fluorescence is measured.  
Light scattering in flow cytometers is a staple phenomenon for detecting and characterising 
particles in FACS and more recently micro-capsules. A light beam directed at a particle can 
interact through reflective, refractive and diffractive effects. Then, information about the 
particle, aggregate or micro-capsule can be derived from the change in direction and 
intensity of a scattered light beam. Collecting scattered light at various angles from the 
incident beam has been reported to provide different types of information about the particle, 
e.g. size and density (Zharinov et al., 2001). The diameter of the particle/ capsule should be 
within the range of 1-50 wavelengths of the incident light beam.  
Typically, forward scatter can provide approximate information about size of a protein gel 
micro-bead or capsule (Shapiro, 2003). It should however, be noted that an increase in the 
intensity of forward-scattered light does not always correlate with increasing particle size. 
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Side scattered light is often collected at 90º and provides information about smaller particles 
and structures within protein particles, scaffold, capsule or gel aggregates. Proportionally 
more light is scattered by micro-capsules or encapsulated structures at a wide angle than at 
a small angle, and thus side-scattered light can provide information about the relative 
roughness or shape of micro-particles and capsules in addition to the granularity of their 
internal structures. Measuring side-scattered light and forward scattered light has become a 
standard FACS for biomedical research because this behaviour enables cells to be 
distinguished by size and granularity, providing insight into mixed populations, viability, 
or change in internal structure of encapsulation entities.  
Using information derived from scatter light at different angles, particles can be classified 
and studied. Zharinov, et al., (2001) used light scattering data from a scanning FACS to 
distinguish lymphocytes, erthyrocytes, encapsulation capsules and milk-fat particles of 
various size and refractive index (Zharinov et al., 2001). These cells and particles generated 
different scattered light profiles dependent on scattering angle. Steen et al., (1990) custom-
built a flow cytometer to characterise viruses of different size using light scattering (Steen et 
al., 1990).This device could easily distinguish particles with diameters in the range of 30-700 
(Steen et al., 1990). In the 1980 Masson and co-workers presented a strong body of work 
describing particle-counting agglutination immunoassays (PACIA) (Sindic et al., 1981). 
Initially, PACIA was publicised as a replacement for expensive assay utilizing radioactive 
labels for characterisation of antigen and antibody interactions. In these assays, polystyrene 
particles coated with antigens were incubated with antibodies to cause agglutination or 
aggregation of the particles. Key aspects of this assay were: 
- Use of an antibody with multivalent binding sites to enable particle-particle interaction  
- Determination of particle concentrations that would allow aggregation; and 
- Prevention of non-specific interactions between particles  
The samples before and after agglutination were measured in an optical particle counter 
based on light scattering. The aggregated particles were larger in size than unaggregated 
particles and resulted in more side-scattered light. In 2003, Pamme, Koyama and Manz 
described a microfluidic device that used light scattering to analyse agglutination immuno 
assays (Pamme et al., 2003). The device used a design that focused particles in two 
dimensions into an optical interrogation region. Particles ranging from 2-9 μm in diameter 
were distinguished, which is significantly larger than the 70-300 nm range reported 
previously (Steen et al., 1990). Light scattering is extensively studied with many advantages 
to developers of microflow cytometry assays for encapsulation purposes. Using just a beam 
of light of suitable wavelength (relative to the capsule) and detectors at various angles, 
information regarding size, shape and granularity of a capsule are easily derived. 
Additionally, scattered light signals tend to be strong and do not need the most advanced or 
expensive detectors. Yet, distinguishing differing in diameter of a few microns can be 
challenging and represents the fundamental pre-requisite for encapsulation screening 
assays.  
4.5 High content encapsulation screening 
Literature also shows that high resolution two-dimensional (2-D) images consume limited 
detector bandwidth, introduce a data-acquisition delay that is a barrier for real-time 
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decisions needed for sorting capsules and introduce noise via inaccuracies in image 
segmentation. This impediment is further addressed to provide the foundation knowledge 
for a parallel microfluidic cytometer (PMC) using a high-speed scanning photomultiplier-
based detector. Development of parallel flow channels within this model PMC would 
inevitably decouple count rates from signal-to-noise ratio for cytometric analysis of 
encapsulation systems. Essentially, this approach would demonstrate the feasibility for high 
throughput visual screening of encapsulated animal cells and stem cell clusters with 
concomitant determination of recombinant protein generation and localisation.  
Imaging flow cytometers based on wide-field-charge-coupled device (CCD) imagers have 
demonstrated throughput limitations similar to those of microscopes (George et al., 2006). 
To address these restrictions, industry has developed a multi-channel parallel 
microfluidic cytometer (PMC) based on analog detection with parallel microfluidics. This 
design may potentially reduce i) data-buffering and storage requirements and ii) simplify 
the classification algorithm required to differentiate encapsulated animal or stem cells. 
Hence, parallel microfluidics will bypass sample-changeover restrictions commonly 
encountered with single channel flow cytometers. This novel strategy will enhance 
process efficiency of the PMC detector by increasing the diameter of a laser spot from 
1 µm and 4 µm. Furthermore, sample flowing into the focal volume will potentially 
eliminate the focusing and stage volumes that limit high content screening on a 
microscope to approx. 2-6 wells min-1. This new cytometric design circumvents many 
throughput limitations for both high cell density encapsulation and flow cytometer 
analysis by combining the best features of each technology to achieve efficient cell 
encapsulation screening.  
Although much can be borrowed from the methods of 2-D high content screening (de Vos et 
al., 2010), 1-D algorithms are fundamentally different. Notably, microscope or flow 
cytometers draw boundaries around ‘primary and secondary objects’ (known as 
segmentation). However, this user-defined aspect of segmentation is a source of assay 
variability and is often considered the most challenging and time-consuming step. However, 
the recent application of 1-D cytometric imaging strategy for encapsulation systems 
integrated resolution issues experience within the standard hardware systems in order to 
eliminate potential segmentation problems. This was achieved by accepting any resolution 
element as an ‘object’. Hence, this demonstrates the feasibility to develop efficient high 
content screening algorithms for micro-capsules using relatively low input.  
5. Conclusion 
Incorporation of bioactive compounds such as probiotics, animal cells and stem cell clusters 
into encapsulation matrices for food and pharmaceutical purposes can provide a simple way 
to develop novel nutraceuticals and drug treatment delivery systems with physiological 
benefits. Exact elucidation of cell proliferation and stability during encapsulation is of 
utmost importance for industrial or academic application. Hence, this chapter outlines the 
importance of cytometric analysis of encapsulation systems, in addition to the role of protein 
during this screening process. Proteins present various challenges for cytometric analysis; 
however, several techniques have been developed to overcome these limitations for 
commercial development of this novel technology. 
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